SEC Form 3 
FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 	  
OMB APPROVAL
OMB Number:	3235-0104	
Estimated average burden	
hours per response:	0.5	

	
1. Name and Address of Reporting Person*
de Guillenchmidt Alec	

(Last)	(First)	(Middle)	
COLGATE-PALMOLIVE COMPANY	
300 PARK AVENUE	

(Street) 
NEW YORK	NY	10022	

(City)	(State)	(Zip)	
	2. Date of Event Requiring Statement (Month/Day/Year)
01/10/2008 	3. Issuer Name and Ticker or Trading Symbol 
COLGATE PALMOLIVE CO [ CL ] 		
		4. Relationship of Reporting Person(s) to Issuer 
(Check all applicable) 
	Director		10% Owner	
X	Officer (give title below)		Other (specify below)	
Pres. Colgate Europe & So.Pac.	
	5. If Amendment, Date of Original Filed (Month/Day/Year)				
			6. Individual or Joint/Group Filing (Check Applicable Line) 
X	Form filed by One Reporting Person	
	Form filed by More than One Reporting Person	
	
Table I - Non-Derivative Securities Beneficially Owned	
1. Title of Security (Instr. 4) 	2. Amount of Securities Beneficially Owned (Instr. 4) 	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 	4. Nature of Indirect Beneficial Ownership (Instr. 5) 	
Common Stock	27,917	D		
Common Stock	138	I	By Issuer's 401(k) Plan Trustee	
Series B Convertible Preference Stock	7	I	By Issuer's 401(k) Plan Trustee	
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) 	
1. Title of Derivative Security (Instr. 4) 	2. Date Exercisable and Expiration Date (Month/Day/Year)	3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 	4. Conversion or Exercise Price of Derivative Security 	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 	6. Nature of Indirect Beneficial Ownership (Instr. 5) 	
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares				
Stock Option (Right to Buy)	09/10/2001(1) 	09/10/2008	Common Stock	8,000	33.7344	D		
Stock Option (Right to Buy)	09/09/2002(1) 	09/09/2009	Common Stock	8,000	55.6563	D		
Stock Option (Right to Buy)	11/04/2004(1) 	11/04/2009	Common Stock	24,000	57.375	D		
Stock Option (Right to Buy)	05/09/2000(1) 	09/10/2008	Common Stock	2,322	58.125	D		
Stock Option (Right to Buy)	09/14/2003(1) 	09/14/2010	Common Stock	9,000	48.0625	D		
Stock Option (Right to Buy)	09/14/2007(1) 	09/14/2010	Common Stock	4,000	48.0625	D		
Stock Option (Right to Buy)	09/17/2004(1) 	09/17/2011	Common Stock	11,000	56.675	D		
Stock Option (Right to Buy)	09/12/2005(1) 	09/12/2012	Common Stock	12,000	55.11	D		
Stock Option (Right to Buy)	09/11/2006(1) 	09/11/2009	Common Stock	10,800	56.565	D		
Stock Option (Right to Buy)	09/09/2007(1) 	09/09/2010	Common Stock	10,800	54.4	D		
Stock Option (Right to Buy)	09/08/2006(2) 	09/08/2011	Common Stock	10,800	53.455	D		
Stock Option (Right to Buy)	09/07/2007(2) 	09/07/2012	Common Stock	13,000	60.68	D		
Stock Option (Right to Buy)	09/12/2008(2) 	09/12/2013	Common Stock	17,500	68.15	D		
Explanation of Responses:	
1. Option became 100% exercisable on the date shown in this column.	
2. Option becomes exercisable in one-third increments on each anniversary date, with the first third becoming exercisable on the date shown in this column.	
Remarks:	
	
	Nina D. Gillman by power of attorney	01/17/2008	
	** Signature of Reporting Person	Date	
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).	
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.	

POWER OF ATTORNEY

FORMS 3, 4 AND 5

I, Alec de Guillenchmidt, an officer of Colgate-Palmolive Company
(the "Company"), do hereby appoint Andrew D. Hendry, Nina D. Gillman,
Nina R. Huffman and J. Thomas Yust, severally, as my true and lawful
attorneys with the power to execute and file on my behalf and in my
place and stead,as I myself could do if I were personally present,
any Form 3, 4 or 5 to be filed by me pursuant to Section 16(a) of
the Securities Exchange Act of 1934 in connection with my ownership,
either directly or indirectly, or any change therein, of securities
of the Company.

This Power of Attorney shall remain in force and effect for
as long as I continue to be an officer of the Company or until earlier
revoked by me in writing and shall not otherwise be affected by my
subsequent disability or incompetence.

In witness whereof, I have signed this instrument
on January 14, 2008.

Signature:  /s/ Alec de Guillenchmidt
Print Name:    Alec de Guillenchmidt